TPG-backed Bicara Therapeutics raises $315 mln in US IPO-February 2024-www.financetom.com

TPG-backed Bicara Therapeutics raises $315 mln in US IPO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

TPG-backed Bicara Therapeutics raises $315 mln in US IPO

Sep 13, 2024 2:07 PM

Sept 12 (Reuters) - Bicara Therapeutics raised

$315 million in its initial public offering in the United

States, the TPG-backed cancer therapy developer said on

Thursday.

Previous page： Bitcoin-Linked Canaan Stock Is Tumbling Thursday: What's Going On? Next page： BRIEF-Arthur J. Gallagher & Co. Acquires Fontenelle & Goodreau Insurance

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Bitcoin-Linked Canaan Stock Is Tumbling Thursday: What's Going On?

Apr 18, 2024

Canaan Inc ( CAN ) shares are falling Thursday after the company filed for a mixed securities shelf offering. What Happened: Late Wednesday, Canaan filed a prospectus related to a mixed shelf offering. The company said it may offer and sell up to $300 million of securities from time to time in one or more offerings. The securities available may include common...

BRIEF-Arthur J. Gallagher & Co. Acquires Fontenelle & Goodreau Insurance

Apr 18, 2024

April 18 (Reuters) - Arthur J Gallagher & Co ( AJG ): * ARTHUR J. GALLAGHER & CO. ( AJG ) ACQUIRES FONTENELLE & GOODREAU INSURANCE, LLC * ARTHUR J GALLAGHER & CO ( AJG ) - TERMS OF TRANSACTION WERE NOT DISCLOSED. Source text for Eikon: Further company coverage: ...

Update: 23andMe CEO Mulls Plan to Take Company Private

Apr 18, 2024

09:35 AM EDT, 04/18/2024 (MT Newswires) -- (Updates with details throughout.) 23andMe Holding Co. ( ME ) Chief Executive Anne Wojcicki has told board members she is considering a plan to acquire the company in a go-private transaction, the company said Thursday in a filing with the US Securities and Exchange Commission. The company said Wojcicki is working with advisors...

WELL Health Maintained at Buy at Stifel GMP as it Buys 10 Clinics From Shoppers Drug Mart; Price Target Kept at C$11.00

Apr 18, 2024

09:41 AM EDT, 04/18/2024 (MT Newswires) -- Stifel GMP on Thursday reiterated its buy rating on the shares of WELL Health Technologies ( WHTCF ) and its C$11.00 price target after the company agreed to acquire 10 primary-care medical clinics from Shoppers Drug Mart. WELL announced the acquisition of all 10 primary care medical clinics owned by Shoppers Drug Mart,...